Sun Pharmaceutical Industries Ltd. reported on March 13, 2014, that FDA had issued an import alert for its cephalosporin facility located at Karkhadi, Gujarat in India. This import alert was issued by FDA as a follow-up to the last inspection of the facility, during which some non-compliance of current good manufacturing practice (cGMP) regulations were identified.

Source: Sun Pharmaceutical and FDA